Cargando…

Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum

Detalles Bibliográficos
Autores principales: Louapre, C., Maillart, E., Roux, T., Pourcher, V., Bussone, G., Lubetzki, C., Papeix, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184008/
https://www.ncbi.nlm.nih.gov/pubmed/32362357
http://dx.doi.org/10.1016/j.neurol.2020.04.009
_version_ 1783526528997392384
author Louapre, C.
Maillart, E.
Roux, T.
Pourcher, V.
Bussone, G.
Lubetzki, C.
Papeix, C.
author_facet Louapre, C.
Maillart, E.
Roux, T.
Pourcher, V.
Bussone, G.
Lubetzki, C.
Papeix, C.
author_sort Louapre, C.
collection PubMed
description
format Online
Article
Text
id pubmed-7184008
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-71840082020-04-27 Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum Louapre, C. Maillart, E. Roux, T. Pourcher, V. Bussone, G. Lubetzki, C. Papeix, C. Rev Neurol (Paris) Article Elsevier Masson SAS. 2020-06 2020-04-27 /pmc/articles/PMC7184008/ /pubmed/32362357 http://dx.doi.org/10.1016/j.neurol.2020.04.009 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Louapre, C.
Maillart, E.
Roux, T.
Pourcher, V.
Bussone, G.
Lubetzki, C.
Papeix, C.
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
title Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
title_full Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
title_fullStr Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
title_full_unstemmed Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
title_short Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum
title_sort patients with ms treated with immunosuppressive agents: across the covid-19 spectrum
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184008/
https://www.ncbi.nlm.nih.gov/pubmed/32362357
http://dx.doi.org/10.1016/j.neurol.2020.04.009
work_keys_str_mv AT louaprec patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum
AT maillarte patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum
AT rouxt patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum
AT pourcherv patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum
AT bussoneg patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum
AT lubetzkic patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum
AT papeixc patientswithmstreatedwithimmunosuppressiveagentsacrossthecovid19spectrum